MARKET

DRIO

DRIO

DarioHealth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.26
-0.04
-0.63%
Opening 09:30 07/16 EDT
OPEN
6.26
PREV CLOSE
6.30
HIGH
6.26
LOW
6.26
VOLUME
2.94K
TURNOVER
--
52 WEEK HIGH
13.13
52 WEEK LOW
3.020
MARKET CAP
23.75M
P/E (TTM)
-0.5414
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average DRIO stock price target is 9.33 with a high estimate of 10.00 and a low estimate of 8.00.

EPS

DRIO News

More
Dennis Matheis, President of Optima Health, a Multi-line Health Plan With More Than 850,000 Members and over 26,000 Providers, and Former President of Anthem Blue Cross and Blue Shield Central Region, Appointed to the Board of DarioHealth Corp
PR Newswire · 07/06 13:30
ThinkEquity Initiates Coverage On DarioHealth with Buy Rating, Announces Price Target of $10
ThinkEquity initiates coverage on DarioHealth (NASDAQ:DRIO) with a Buy rating and announces Price Target of $10.
Benzinga · 06/22 11:11
Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions
PR Newswire · 06/18 13:30
DarioHealth Announces Participation in the Virtual Going Digital: Behavioral Health Tech Summit
PR Newswire · 06/17 13:30
DarioHealth Presents New Studies Demonstrating Sustained Improvements in Blood Glucose and Blood Pressure Control in Users with Diabetes and Hypertension at the American Diabetes Association's 80th Scientific Sessions
PR Newswire · 06/15 13:30
DarioHealth Highlights Presentation Of New Studies Showing Sustained Improvements In Blood Glucose, Blood Pressure Control In Users With Diabetes, Hypertension At American Diabetes Association
DarioHealth Corp. (NASDAQ:DRIO), a leading global digital therapeutics (DTx) company, presented the results of two new studies at the American Diabetes Association's (ADA) 80th Scientific Sessions that showed
Benzinga · 06/15 12:34
DarioHealth Announces Two Remote Patient Monitoring (RPM) Agreements and Commences Enrollment
PR Newswire · 06/11 13:30
DarioHealth up big on remote patient monitoring deals
Seeking Alpha - Article · 06/11 13:12

Industry

Medical Equipment, Supplies & Distribution
-0.77%
Healthcare Equipment & Supplies
-0.62%

Hot Stocks

Symbol
Price
%Change

About DRIO

DarioHealth Corp, formerly Labstyle Innovations Corp, is a digital health (mHealth) company. The Company is engaged in developing and commercializing a technology providing consumers with laboratory-testing capabilities using smart phones and other mobile devices. The Company's product, Dario, also known as Dario Smart Diabetes Management Solution, is a mobile, real-time, cloud-based, diabetes management solution based on a software application combined with a pocket-sized, blood glucose monitoring device, Dario Smart Meter. The Dario product is a digital diabetes management solution utilizing its technology delivered through a software application available for iPhone or Android and cloud-based data services with a blood glucose monitoring system device. Dario allows users to record, analyze, transmit and store various data points, such as glucose level, insulin and carbohydrate intake. It markets the Dario Smart Diabetes Management Solution in the Netherlands and New Zealand.
More

Webull offers kinds of DarioHealth Corp stock information, including NASDAQ:DRIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DRIO stock methods without spending real money on the virtual paper trading platform.